IGMS
Income statement / Annual
Last year (2023), IGM Biosciences, Inc.'s total revenue was $2.13 M,
an increase of 99.25% from the previous year.
In 2023, IGM Biosciences, Inc.'s net income was -$246.42 M.
See IGM Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
Operating Revenue |
$2.13 M
|
$1.07 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$8.28 M |
$10.60 M |
$7.72 M |
$3.58 M |
$2.33 M |
$278,000.00 |
$161,000.00 |
Gross Profit |
-$6.15 M |
-$9.53 M |
-$7.72 M |
-$3.58 M |
-$2.33 M |
-$278,000.00 |
-$161,000.00 |
Gross Profit Ratio |
-2.89 |
-8.92 |
0 |
0 |
0 |
0 |
0 |
Research and Development
Expenses |
$207.24 M
|
$179.29 M
|
$127.03 M
|
$65.03 M
|
$35.26 M
|
$18.96 M
|
$8.64 M
|
General & Administrative
Expenses |
$50.07 M
|
$49.74 M
|
$38.30 M
|
$18.25 M
|
$9.24 M
|
$3.83 M
|
$2.51 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$50.07 M
|
$49.74 M
|
$38.30 M
|
$18.25 M
|
$9.24 M
|
$3.83 M
|
$2.51 M
|
Other Expenses |
-$20,000.00 |
-$181,000.00 |
$159,000.00 |
$1.93 M |
$1.37 M |
$80,000.00 |
$93,000.00 |
Operating Expenses |
$257.31 M |
$229.03 M |
$165.32 M |
$83.28 M |
$44.50 M |
$22.79 M |
$11.15 M |
Cost And Expenses |
$265.59 M |
$229.03 M |
$165.32 M |
$83.28 M |
$44.50 M |
$22.79 M |
$11.15 M |
Interest Income |
$17.74 M |
$7.04 M |
$159,000.00 |
$1.93 M |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$0.00 |
-$6.85 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$8.28 M
|
$10.60 M
|
$7.72 M
|
$3.58 M
|
$2.33 M
|
$278,000.00
|
$161,000.00
|
EBITDA |
-$255.18 M
|
-$227.96 M
|
-$165.32 M
|
-$83.28 M
|
-$44.50 M
|
-$22.51 M
|
-$10.99 M
|
EBITDA Ratio |
-119.8 |
-213.24 |
0 |
0 |
0 |
0 |
0 |
Operating Income Ratio
|
-123.69
|
-213.24
|
0
|
0
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
$17.72 M
|
$6.85 M
|
$159,000.00
|
$1.93 M
|
$1.37 M
|
$80,000.00
|
$93,000.00
|
Income Before Tax |
-$245.74 M |
-$221.10 M |
-$165.16 M |
-$81.36 M |
-$43.13 M |
-$22.71 M |
-$11.05 M |
Income Before Tax Ratio
|
-115.37
|
-206.83
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$678,000.00 |
-$6.85 M |
-$4.48 M |
-$1.03 M |
-$597,000.00 |
$80,000.00 |
$0.00 |
Net Income |
-$246.42 M |
-$214.25 M |
-$160.68 M |
-$80.33 M |
-$42.54 M |
-$22.71 M |
-$11.05 M |
Net Income Ratio |
-115.69 |
-200.42 |
0 |
0 |
0 |
0 |
0 |
EPS |
-4.71 |
-5.16 |
-4.8 |
-2.61 |
-4.73 |
-51.84 |
-25.24 |
EPS Diluted |
-4.71 |
-5.16 |
-4.8 |
-2.61 |
-4.73 |
-51.84 |
-25.24 |
Weighted Average Shares
Out |
$52.31 M
|
$41.54 M
|
$33.48 M
|
$30.75 M
|
$9.00 M
|
$438,074.00
|
$437,942.00
|
Weighted Average Shares
Out Diluted |
$52.31 M
|
$41.54 M
|
$33.48 M
|
$30.75 M
|
$9.00 M
|
$438,074.00
|
$437,942.00
|
Link |
|
|
|
|
|
|
|